Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 24768611)

1.

Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.

Kurtzwald-Josefson E, Hochhauser E, Bogachenko K, Harun-Khun S, Katz G, Aravot D, Seidman JG, Seidman CE, Eldar M, Shainberg A, Arad M.

Heart Rhythm. 2014 Aug;11(8):1471-9. doi: 10.1016/j.hrthm.2014.04.030. Epub 2014 Apr 21.

2.

Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.

Katz G, Khoury A, Kurtzwald E, Hochhauser E, Porat E, Shainberg A, Seidman JG, Seidman CE, Lorber A, Eldar M, Arad M.

Heart Rhythm. 2010 Nov;7(11):1676-82. doi: 10.1016/j.hrthm.2010.07.004. Epub 2010 Jul 8.

3.

The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2).

Katz G, Shainberg A, Hochhauser E, Kurtzwald-Josefson E, Issac A, El-Ani D, Aravot D, Afek A, Seidman JG, Seidman CE, Eldar M, Arad M.

Biochem Pharmacol. 2013 Dec 1;86(11):1576-83. doi: 10.1016/j.bcp.2013.09.012. Epub 2013 Sep 23.

4.

Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.

Alcalai R, Wakimoto H, Arad M, Planer D, Konno T, Wang L, Seidman JG, Seidman CE, Berul CI.

J Cardiovasc Electrophysiol. 2011 Mar;22(3):316-24. doi: 10.1111/j.1540-8167.2010.01877.x. Epub 2010 Aug 30.

5.

Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.

Khoury A, Marai I, Suleiman M, Blich M, Lorber A, Gepstein L, Boulos M.

Heart Rhythm. 2013 Nov;10(11):1671-5. doi: 10.1016/j.hrthm.2013.08.011. Epub 2013 Aug 13.

PMID:
23954267
6.

Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.

Hwang HS, Hasdemir C, Laver D, Mehra D, Turhan K, Faggioni M, Yin H, Knollmann BC.

Circ Arrhythm Electrophysiol. 2011 Apr;4(2):128-35. doi: 10.1161/CIRCEP.110.959916. Epub 2011 Jan 26.

7.

Exercise training improves cardiac function and attenuates arrhythmia in CPVT mice.

Kurtzwald-Josefson E, Hochhauser E, Katz G, Porat E, Seidman JG, Seidman CE, Chepurko Y, Shainberg A, Eldar M, Arad M.

J Appl Physiol (1985). 2012 Dec 1;113(11):1677-83. doi: 10.1152/japplphysiol.00818.2012. Epub 2012 Oct 4.

8.

Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.

Song L, Alcalai R, Arad M, Wolf CM, Toka O, Conner DA, Berul CI, Eldar M, Seidman CE, Seidman JG.

J Clin Invest. 2007 Jul;117(7):1814-23.

9.

A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.

Dirksen WP, Lacombe VA, Chi M, Kalyanasundaram A, Viatchenko-Karpinski S, Terentyev D, Zhou Z, Vedamoorthyrao S, Li N, Chiamvimonvat N, Carnes CA, Franzini-Armstrong C, Györke S, Periasamy M.

Cardiovasc Res. 2007 Jul 1;75(1):69-78. Epub 2007 Mar 12.

10.

Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.

Watanabe H, Knollmann BC.

J Electrocardiol. 2011 Nov-Dec;44(6):650-5. doi: 10.1016/j.jelectrocard.2011.07.025. Epub 2011 Aug 27.

PMID:
21872879
11.

The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice.

Zhang J, Chen B, Zhong X, Mi T, Guo A, Zhou Q, Tan Z, Wu G, Chen AW, Fill M, Song LS, Chen SR.

Biochem J. 2014 Jul 1;461(1):99-106. doi: 10.1042/BJ20140126.

12.

Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.

Faggioni M, Hwang HS, van der Werf C, Nederend I, Kannankeril PJ, Wilde AA, Knollmann BC.

Circ Res. 2013 Feb 15;112(4):689-97. doi: 10.1161/CIRCRESAHA.111.300076. Epub 2013 Jan 7.

13.

Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.

Novak A, Barad L, Zeevi-Levin N, Shick R, Shtrichman R, Lorber A, Itskovitz-Eldor J, Binah O.

J Cell Mol Med. 2012 Mar;16(3):468-82. doi: 10.1111/j.1582-4934.2011.01476.x.

14.

Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.

Kalyanasundaram A, Viatchenko-Karpinski S, Belevych AE, Lacombe VA, Hwang HS, Knollmann BC, Gyorke S, Periasamy M.

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H253-61. doi: 10.1152/ajpheart.00578.2011. Epub 2011 Oct 7.

15.

Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.

Terentyev D, Nori A, Santoro M, Viatchenko-Karpinski S, Kubalova Z, Gyorke I, Terentyeva R, Vedamoorthyrao S, Blom NA, Valle G, Napolitano C, Williams SC, Volpe P, Priori SG, Gyorke S.

Circ Res. 2006 May 12;98(9):1151-8. Epub 2006 Apr 6.

16.

Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin.

Galimberti ES, Knollmann BC.

J Mol Cell Cardiol. 2011 Nov;51(5):760-8. doi: 10.1016/j.yjmcc.2011.07.002. Epub 2011 Jul 12.

17.

Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias.

Denegri M, Avelino-Cruz JE, Boncompagni S, De Simone SA, Auricchio A, Villani L, Volpe P, Protasi F, Napolitano C, Priori SG.

Circ Res. 2012 Mar 2;110(5):663-8. doi: 10.1161/CIRCRESAHA.111.263939. Epub 2012 Jan 31.

18.

Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.

Chopra N, Kannankeril PJ, Yang T, Hlaing T, Holinstat I, Ettensohn K, Pfeifer K, Akin B, Jones LR, Franzini-Armstrong C, Knollmann BC.

Circ Res. 2007 Sep 14;101(6):617-26. Epub 2007 Jul 26.

19.

Calsequestrin 2 and arrhythmias.

Faggioni M, Knollmann BC.

Am J Physiol Heart Circ Physiol. 2012 Mar 15;302(6):H1250-60. doi: 10.1152/ajpheart.00779.2011. Epub 2011 Dec 23. Review.

20.

Catecholaminergic Polymorphic Ventricular Tachycardia.

Napolitano C, Priori SG, Bloise R.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015.
2004 Oct 14 [updated 2014 Mar 6].

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk